Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study

NCT07821008 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07821008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07821008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study
Lead sponsor
University Hospital, Toulouse
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 14, 2026
Completion date
December 14, 2029
Enrollment
274 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

brain ischemia, endovascular procedure, subarachnoid hemorrhage, aneurysmal